STEVEN TISH began his career at Lazard Freres Asset Management in 1991 as an analyst/portfolio manager. He covered industries including technology, healthcare, business services, and conglomerates. Steve then moved to PAW Partners in Greenwich as a partner and analyst/portfolio manager where he was responsible for the P&L of the healthcare segment of a multi-sector hedge fund. He then joined Millennium Partners in New York as a partner and analyst/portfolio manager where he worked with a team which was dedicated to their global healthcare hedge fund. The members of the team later left Millennium to start Panacea Asset Management, an independent healthcare sector hedge fund in New York. He joined DSM Capital Partners in October 2007. Steve earned a B.S. in Finance from the University of Maryland and an MBA from Cornell University. He was awarded his Chartered Financial Analyst certification in 1994.

Justin Burk joined DSM in 2002 as a portfolio manager/research analyst. Previously, he joined Moody’s Investor Services in 1998, moving to Carlyle High Yield Partners as an analyst in 1999. In 2001 he joined Aslan Capital Management, a high yield event-driven hedge fund, where he specialized in corporate structure analysis and asset valuation. Justin received an A.B. in Biochemical Sciences with Honors from Harvard University, and holds a Chartered Financial Analyst designation.

DAVID MCVEY started in 1992 at Mutual Funds Service Company in Boston. In 1995 he became equity research associate for biotechnology and healthcare at Hambrecht & Quist. He then moved to Furman Selz, becoming a vice president and serving as media and entertainment analyst. Most recently, he has been media and entertainment associate analyst at J.P. Morgan H&Q. David received a Bachelor of Science degree in Economics and Finance from New Hampshire College, and holds a Chartered Financial Analyst designation. David joined DSM in 2001.

ERIC WOODWORTH joined Price Waterhouse Coopers in 1994 as a technology consultant. He became a team leader and managed projects for PWC in Toronto and Chicago. He also served as an internal instructor for PWC in Tampa, Florida. Eric left PWC in 1999 to attend business school, spending his summer in equity research at Merrill Lynch. Eric holds a Bachelor of Arts in Economics from Williams College, an MBA in Finance from New York University, and holds a Chartered Financial Analyst designation. Eric joined DSM in 2001.

PINAKI KAR started his career in life-sciences strategy consulting at ZA Associates in 1994 where he advised pharmaceutical and biotechnology clients. He subsequently worked at Pfizer and Bristol-Myers Squibb in various roles within brand planning and management. His most recent role was at Novartis AG where he was responsible for screening and assessing strategic investment opportunities. Pinaki holds a Bachelors in Mechanical Engineering from the Indian Institute of Technology and a Masters in Logistics from the Massachusetts Institute of Technology, where he was on the Deans List. He also holds a Masters in Engineering from Notre Dame and an MBA in Finance from New York University, where he earned the Stern Scholar designation. Pinaki joined DSM in 2008.

DANIEL STRICKBERGER began his career in 1979 as a credit analyst, first at Morgan Guaranty, and later at Bank of Tokyo. He joined Oppenheimer & Co. as a securities analyst in 1982. He joined Lazard Freres & Co. later that year, after Oppenheimer & Co. was sold. Dan was appointed Director of Research of Lazard Freres Asset Management in 1987 and was made a general partner of Lazard Freres & Co. in 1988. He was one of two senior portfolio managers supervising Lazard’s domestic equity investments. Dan also developed and was the senior portfolio manager of Lazard’s international equities portfolio.

HANNAH CHIANG began her career at American Century Investment Management in 1997. From 2001-2005 she was a research analyst for international equities. She was then named an associate analyst responsible for large cap ideas in Asia (ex-Japan). For the last six years, Hannah was a senior investment analyst focusing on large cap global consumer companies. She holds a Bachelor of Science in International Business and a Master of Science in Finance, both from the University of Colorado. Hannah joined DSM in 2015.

TAKAMUNE FUJIKAWA began his career in 1994 at Nomura Securities International in New York as a quantitative analyst. In 2008, he joined The Boston Company Asset Management as a senior international equity analyst. Taka continued his career in Hong Kong at Hutchinhill Capital as a senior equity analyst. His most recent role was a senior analyst at the equity research department in SMBC Nikko Securities in Tokyo. He received a Bachelor of Science degree in Finance and International Business from New York University, Stern School of Business. He holds a Chartered Financial Analyst designation. Taka joined DSM in May 2018.

SHIRLEY HU ANDERSON began her career as an analyst in the Technology Investment Banking Group at Credit Suisse. In 2008, she joined Qatalyst Partners, a technology-focused M&A investment bank, as a founding member of the team. In 2014, she moved to Bernstein Research as a senior research associate, where her team was ranked #1 by Institutional Investor for their coverage of semiconductors. Shirley was most recently a senior analyst in technology, media and telecom with Alliance Bernstein’s Arya Partners. She graduated from Princeton University with a BA in public and international affairs and received her MBA from The Wharton School, University of Pennsylvania. Shirley holds a Chartered Financial Analyst designation. She joined DSM in 2021.